Express Scripts still waiting for US FTC settlement to be finalized
By Alex Wilts ( September 14, 2026, 23:43 GMT | Insight) -- Express Scripts is still waiting for its settlement with the US Federal Trade Commission in litigation over insulin drug pricing to be finalized before dismissing its separate action against the agency over a July 2024 FTC staff report on the pharmacy benefit management industry.Express Scripts is still waiting for its settlement with the US Federal Trade Commission in litigation over insulin drug pricing to be finalized before dismissing its separate action against the agency over a July 2024 FTC staff report on the pharmacy benefit management (PBM) industry....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.